Discussion about this post

User's avatar
Chris Buck's avatar

Great post! I wish more scientists would share technical ideas in exactly this way! I've got one suggestion and one bit of blue sky speculation.

Suggestion: I have happy memories of mastering crossflow while helping my postdoctoral mentors develop HPV vaccines a quarter century ago - but in the years since then I've almost entirely shifted to using Optiprep to concentrate and purify viruses. It's great for smaller-scale work. Here's a detailed protocol:

https://ccrod.cancer.gov/confluence/display/LCOTF/PseudovirusProduction

Consider it my bona fides on the suggestion that more scientists should publicly share technical ideas!

Speculation: How much purity do you actually need here? The FDA appropriately sets endotoxin limits for things that will be injected, but pseudomonas sometimes causes skin/lung/gut infections that might theoretically be best addressed by applying the phages topical/aerosol/oral. The FDA doesn't set endotoxin limits for foods, cosmetics, or dietary supplements - so it's not clear to me what the scientific rationale might be for limiting endotoxin in phage preps that will be administered via the same routes as foods, cosmetics, and supplements.

Expand full comment
Jessica Sacher, PhD's avatar

Ah yes! I totally agree with you on that. At least when I was in Australia, their drug committees (and TGA) were very reasonable about requiring more purity than necessary. We would treat oral or topical infections with freshly made phage lysates on occasion (these were the minority though because doctors wanted to treat IV usually). Now I’m back in the US and I have yet to be on the producer side of a compassionate case - it will be interesting to see what FDA is like by comparison. In urgent cases from what I’ve heard they’re also very amenable. And purification is achievable for an academic lab at this point, as long as they have someone to do the work. So I don’t know if I’d say purification barriers for compassionate cases are directly preventing actual treatments/lives saved right now. It’s more that it’s no one’s job to do it (since it’s not reimbursable until the clinical trials are done), and thus most patients/docs don’t even know about it.

Expand full comment
8 more comments...

No posts